Derby, Connecticut 06418

  • Fibromyalgia


The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.

Study summary:

As per Brief Summary


Inclusion criteria: - Meet the American College of Rheumatology criteria for Fibromyalgia diagnosis; - On no medication for Fibromyalgia other than acetaminophen, or willing to stop all such medication for the duration of the study - Willing to stop all FMS medication for the duration of the study or be on a stable dose of such medication for at least 3 months Exclusion criteria: - Other concurrent medical conditions such as rheumatologic disease, chronic infection, untreated endocrine disorders, unstable seizures, psychiatric disorders, acute peptic ulcer disease, congestive heart failure, chronic liver disorders and/or bleeding problems - Allergy to thiamin - Unwilling to stop vitamin supplementation for the duration of the study - PLEASE NOTE: Travel to and accomodations at the study site can NOT be compensated. Anyone wishing to travel from outside of the study site's geographic area must do so at their own risk and expense.



Primary Contact:

Principal Investigator
David Katz, MD
Yale-Griffin Prevention Research Center

Backup Contact:


Location Contact:

Derby, Connecticut 06418
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source:

Date Processed: April 03, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on The form below is not enabled.